Douglas B. Fox

1.8k total citations
8 papers, 505 citations indexed

About

Douglas B. Fox is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Douglas B. Fox has authored 8 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Douglas B. Fox's work include Cancer Cells and Metastasis (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Douglas B. Fox is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Douglas B. Fox collaborates with scholars based in United States, Hong Kong and Denmark. Douglas B. Fox's co-authors include Matthew D. Hirschey, Paul A. Grimsrud, Christian A. Olsen, Eoin McDonnell, Olga Ilkayeva, Scott B. Crown, James V. Alvarez, Ryan Lupo, Rachel Newcomb and Brock J. McKinney and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Cell Reports.

In The Last Decade

Douglas B. Fox

8 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas B. Fox United States	7	358	191	117	67	57	8	505
Chunping Qiu China	19	432 1.2×	282 1.5×	119 1.0×	31 0.5×	128 2.2×	31	741
Tania Valencia United States	8	380 1.1×	229 1.2×	142 1.2×	33 0.5×	61 1.1×	10	574
Bincy Philip United States	2	254 0.7×	223 1.2×	169 1.4×	52 0.8×	66 1.2×	2	455
Christoph Wohlkoenig Austria	7	281 0.8×	189 1.0×	80 0.7×	32 0.5×	44 0.8×	9	413
Paula P. Coelho Canada	7	336 0.9×	174 0.9×	50 0.4×	45 0.7×	35 0.6×	9	457
Avi Kumar United States	6	328 0.9×	169 0.9×	80 0.7×	33 0.5×	49 0.9×	12	489
Prashant Bommi United States	11	397 1.1×	124 0.6×	142 1.2×	29 0.4×	22 0.4×	15	506
Rosario Avolio Italy	13	403 1.1×	230 1.2×	83 0.7×	36 0.5×	43 0.8×	16	533
Wenzhe Si China	13	647 1.8×	234 1.2×	163 1.4×	23 0.3×	77 1.4×	17	799
Tanesha Naiken France	4	281 0.8×	215 1.1×	67 0.6×	30 0.4×	48 0.8×	5	383

Countries citing papers authored by Douglas B. Fox

Since Specialization

Citations

This map shows the geographic impact of Douglas B. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas B. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas B. Fox more than expected).

Fields of papers citing papers by Douglas B. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas B. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas B. Fox. The network helps show where Douglas B. Fox may publish in the future.

Co-authorship network of co-authors of Douglas B. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas B. Fox. A scholar is included among the top collaborators of Douglas B. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas B. Fox. Douglas B. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Fox, Douglas B., Richard Y. Ebright, Xin Hong, et al.. (2023). Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade. npj Precision Oncology. 7(1). 25–25. 7 indexed citations

2.

Sundaresan, Tilak, Taronish D. Dubash, Zongli Zheng, et al.. (2021). Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA. Breast Cancer Research and Treatment. 188(1). 43–52. 13 indexed citations

3.

Walens, Andrea, Jiaxing Lin, Jeffrey S. Damrauer, et al.. (2020). Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence. Nature Communications. 11(1). 5017–5017. 34 indexed citations

4.

Fox, Douglas B., Brock J. McKinney, Ryan Lupo, et al.. (2020). NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism. Nature Metabolism. 2(4). 318–334. 144 indexed citations

5.

Fox, Douglas B., et al.. (2019). Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes. Molecular Cancer Research. 17(7). 1545–1555. 19 indexed citations

6.

Mabe, Nathaniel W., Douglas B. Fox, Ryan Lupo, et al.. (2018). Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer. Journal of Clinical Investigation. 128(10). 4413–4428. 34 indexed citations

7.

McDonnell, Eoin, Scott B. Crown, Douglas B. Fox, et al.. (2016). Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation. Cell Reports. 17(6). 1463–1472. 250 indexed citations

8.

Santini, Daniele, Douglas B. Fox, Robert A. Kloner, et al.. (1980). Pulmonary hypertension in systemic lupus erythematosus: Hemodynamics and effects of vasodilator therapy. Clinical Cardiology. 3(6). 406–411. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact